Treated by Dr. Dasari Keerthi Kumar at Harsha Sai Eye Hospital
Diabetic Retinopathy is a serious diabetes complication affecting the blood vessels of the retina in patients across Nizamabad and surrounding regions. This progressive condition can lead to vision loss if left untreated, making early detection and timely intervention crucial. At Harsha Sai Eye Hospital, Dr. Dasari Keerthi Kumar provides comprehensive diabetic eye care using advanced diagnostic technology and evidence-based treatment protocols to preserve vision and prevent complications.
The early stage where retinal blood vessels weaken and develop microaneurysms, leading to leakage of fluid and blood into the retina. This stage ranges from mild to severe based on the extent of vascular damage and retinal changes.
The advanced stage characterized by growth of abnormal new blood vessels on the retina surface and into the vitreous cavity. These fragile vessels can bleed easily, causing vision loss and potentially leading to retinal detachment.
A complication where fluid accumulates in the macula, the central part of the retina responsible for sharp vision. This can occur at any stage of diabetic retinopathy and is a leading cause of vision loss in diabetic patients.
Multiple factors can contribute to the development and progression of this condition.
Diabetic Retinopathy develops gradually. Recognising symptoms early gives you more treatment options.
From conservative to surgical — we always start with the least invasive option first.
A structured, patient-first approach from first visit to full recovery.
At Harsha Sai Eye Hospital, Dr. Keerthi Kumar performs detailed dilated fundus examination using advanced imaging including OCT, fundus photography, and fluorescein angiography to accurately stage diabetic retinopathy and identify macular edema or proliferative changes requiring intervention.
Based on the severity and type of retinopathy, our team develops individualized treatment protocols that may include observation with close monitoring, anti-VEGF injections, laser photocoagulation, or surgical intervention. We coordinate care with your diabetes management team for optimal outcomes.
Our facility is equipped with state-of-the-art technology for intravitreal injections performed under strict sterile protocols, pattern scanning laser systems for precise photocoagulation, and modern vitrectomy equipment for surgical cases. Dr. Keerthi Kumar ensures each procedure is performed with meticulous technique and patient comfort.
Diabetic retinopathy requires lifelong surveillance even after successful treatment. We establish regular follow-up schedules tailored to disease severity, provide patient education on warning signs, and maintain close communication with referring physicians to ensure comprehensive diabetes care and prevent vision loss.
What to expect at each phase of recovery.
Following anti-VEGF injections, patients may experience mild discomfort, redness, or floaters for 24-48 hours. After laser treatment, vision may be temporarily blurred for several days. Vitrectomy patients require specific positioning and activity restrictions, with vision gradually improving over weeks to months.
Over 4-12 weeks, macular edema typically improves with anti-VEGF therapy, and proliferative disease stabilizes with laser treatment. Multiple injection treatments may be needed. Regular monitoring with OCT imaging tracks fluid resolution and guides ongoing treatment decisions to optimize visual recovery.
Continued diabetes control remains essential for preventing recurrence. Patients require regular retinal examinations every 3-12 months depending on disease severity. Some patients need ongoing anti-VEGF injections on a treat-and-extend schedule. Early detection of progression allows timely intervention to preserve vision long-term.
With timely treatment, especially anti-VEGF therapy for macular edema, many patients experience significant vision improvement or stabilization. Early intervention prevents progression to vision-threatening stages, and even advanced cases can achieve functional vision recovery with appropriate surgical management.
Regular screening and treatment significantly reduce the risk of severe vision loss and blindness from diabetic retinopathy. Pan-retinal photocoagulation and anti-VEGF therapy effectively prevent proliferative complications, while vitrectomy addresses advanced disease before irreversible damage occurs.
Patients who maintain excellent diabetes control and undergo early treatment often require less frequent injections over time and avoid the need for surgical intervention. Proactive management allows for observation-only status in mild cases or controlled stable disease in more advanced stages.
Successful treatment enables patients to maintain independence in daily activities including reading, driving, and work. Preserved central vision allows continued engagement in hobbies and social interactions, while reduced anxiety about blindness improves overall well-being and mental health outcomes.
Untreated diabetic retinopathy progresses inexorably, leading to severe and often irreversible vision loss or complete blindness. Proliferative disease can cause vitreous hemorrhage, tractional retinal detachment, and neovascular glaucoma—all sight-threatening emergencies. Early diabetic macular edema that could be easily treated with injections may lead to permanent central vision damage if neglected, significantly impacting quality of life and independence.
All diabetic patients should undergo comprehensive dilated eye examinations annually, or more frequently if retinopathy is detected. Seek immediate care if you experience sudden vision loss, a shower of new floaters, flashing lights, a curtain or shadow across your vision, or significant changes in visual clarity. Even without symptoms, regular screening is critical as diabetic retinopathy often develops silently in early stages when treatment is most effective.
Early treatment means more options and better outcomes. Book a consultation to understand your condition and explore the right path forward.
